James Mark

About

James Mark is an Assistant Professor at Thomas Jefferson University in the United States. His research areas primarily focus on urologic oncology, exploring topics such as germline testing guidelines, robotic surgery for renal cell carcinoma, and complications associated with various treatment modalities. Recent publications include studies on the efficacy of risk-enabled therapy for bladder cancer and the use of technology to enhance genetic evaluation for prostate cancer. He is also involved in examining the outcomes of active surveillance for intermediate risk prostate cancer.